Tundidor, IsabelSeijo Vila, MartaBlasco-Benito, SandraRubert-Hernández, MaríaMoreno-Bueno, GemaBindila, LauraFernández de la Rosa, RubénGuzmán Pastor, ManuelSánchez García, María CristinaPérez Gómez, Eduardo2024-03-212024-03-212024-01-06Tundidor I, Seijo-Vila M, Blasco-Benito S, Rubert-Hernández M, Moreno-Bueno G, Bindila L, de la Rosa RF, Guzmán M, Sánchez C, Pérez-Gómez E. Fatty acid amide hydrolase drives adult mammary gland development by promoting luminal cell differentiation. Cell Death Discov. 2024 Jan 6;10(1):12. doi: 10.1038/s41420-023-01788-1. PMID: 38184644; PMCID: PMC10771414.10.1038/s41420-023-01788-1https://hdl.handle.net/20.500.14352/102453Mammary gland development occurs primarily in adulthood, undergoing extensive expansion during puberty followed by cycles of functional specialization and regression with every round of pregnancy/lactation/involution. This process is ultimately driven by the coordinated proliferation and differentiation of mammary epithelial cells. However, the endogenous molecular factors regulating these developmental dynamics are still poorly defined. Endocannabinoid signaling is known to determine cell fate-related events during the development of different organs in the central nervous system and the periphery. Here, we report that the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) plays a pivotal role in adult mammary gland development. Specifically, it is required for luminal lineage specification in the mammary gland, and it promotes hormone-driven secretory differentiation of mammary epithelial cells by controlling the endogenous levels of anandamide and the subsequent activation of cannabinoid CB1 receptors. Together, our findings shed light on the role of the endocannabinoid system in breast development and point to FAAH as a therapeutic target in milk-production deficits.engjournal article2058-7716https://www.nature.com/articles/s41420-023-01788-1open access577.1Fatty acid amide hydrolaseAdult mammary glandBioquímica (Biología)2403 Bioquímica